Document is current
Any future updates will be listed below
-
Authors
Nachbagauer, Raffael https://orcid.org/0000-0001-5568-5420
Salaun, Bruno https://orcid.org/0000-0002-8927-8660
Stadlbauer, Daniel https://orcid.org/0000-0001-6792-7650
Behzadi, Mohammad A. https://orcid.org/0000-0002-1691-6123
Friel, Damien https://orcid.org/0000-0001-7284-8949
Rajabhathor, Arvind https://orcid.org/0000-0003-0847-8749
Choi, Angela https://orcid.org/0000-0002-4131-2292
Albrecht, Randy A. https://orcid.org/0000-0003-4008-503X
Debois, Muriel https://orcid.org/0000-0002-3027-2184
García-Sastre, Adolfo https://orcid.org/0000-0002-6551-1827
Rouxel, Ronan N. https://orcid.org/0000-0003-1664-5615
Sun, Weina https://orcid.org/0000-0002-2435-5047
Palese, Peter https://orcid.org/0000-0002-0337-5823
Mallett, Corey P. https://orcid.org/0000-0002-6232-8111
Innis, Bruce L. https://orcid.org/0000-0002-1753-7248
Krammer, Florian https://orcid.org/0000-0003-4121-776X
Claeys, Carine https://orcid.org/0000-0002-5193-8352
- License Information
-
More Information
Article History
Received: 19 September 2019
Accepted: 13 November 2019
First Online: 6 December 2019
Competing interests
: F.K., A.G.-S., and P.P. report study funding from the GSK group of companies. R.N., A.G.-S., P.P., F.K., C.P.M., and B.L.I. are named as inventor on a patent family regarding influenza virus vaccine constructs filed by the Icahn School of Medicine at Mount Sinai and the GSK group of companies. A.G.-S. also reports he is an inventor of a Mount Sinai owned patent on plasmid-based rescue technologies to generate recombinant influenza viruses with royalties paid to Medimmune. R.A.A. reports grants from National Institutes of Health, outside the submitted work. B.S., D.F., M.D., R.N.R., and C.P.M. are employed by the GSK group of companies. B.S., M.D., C.P.M., and C.C. hold shares in the GSK group of companies. C.C. and B.L.I. were employed by the GSK group of companies at the time of the study. D.S., M.A.B., A.C., W.S., and A.R. have nothing to disclose.
